Perrigo (PRGO) Payables (2013 - 2026)
Perrigo's (PRGO) quarterly Payables came in at $434.8 million in Q1 2026, down 13.44% year-on-year from $502.3 million in Q1 2025, and down 8.37% on a QoQ basis from $474.5 million in Q4 2025.
Perrigo (PRGO) Payables (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Payables data on file, last reported at $434.8 million in Q1 2026.
- On a quarterly basis, Payables fell 13.44% year-over-year to $434.8 million in Q1 2026; TTM through Mar 2026 was $434.8 million, a 13.44% decrease from a year earlier, with the FY2025 full-year figure at $474.5 million, down 4.18% from the prior year.
- Payables for Q1 2026 stood at $434.8 million, down from $474.5 million in the prior quarter.
- Over the last five years, Payables for PRGO reached as high as $537.3 million in Q4 2022 and fell as low as $433.1 million in Q3 2023.
- Historically, Payables has averaged $476.7 million across 5 years, with a median of $474.5 million in 2025.
- Across the five-year window, Payables jumped 30.67% in 2022 and retreated 13.44% in 2026, its largest moves.
- Year by year, Payables stood at $537.3 million in 2022, then declined by 11.09% to $477.7 million in 2023, then increased by 3.66% to $495.2 million in 2024, then declined by 4.18% to $474.5 million in 2025, then decreased by 8.37% to $434.8 million in 2026.
- Per Business Quant data, the three most recent Payables figures were $434.8 million in Q1 2026, $474.5 million in Q4 2025, and $469.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | 434.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 434.80 Mn |
| Dec 31, 2025 | 474.50 Mn |
| Sep 27, 2025 | 469.70 Mn |
| Jun 28, 2025 | 489.00 Mn |
| Mar 29, 2025 | 502.30 Mn |
| Dec 31, 2024 | 495.20 Mn |
| Sep 28, 2024 | 458.50 Mn |
| Jun 29, 2024 | 471.50 Mn |
| Mar 30, 2024 | 453.70 Mn |
| Dec 31, 2023 | 477.70 Mn |
| Sep 30, 2023 | 433.10 Mn |
| Jul 1, 2023 | 470.50 Mn |
| Apr 1, 2023 | 505.20 Mn |
| Dec 31, 2022 | 537.30 Mn |
| Oct 1, 2022 | 461.40 Mn |
| Jul 2, 2022 | 490.40 Mn |
| Apr 2, 2022 | 479.60 Mn |
| Dec 31, 2021 | 411.20 Mn |
| Oct 2, 2021 | 405.60 Mn |
| Jul 3, 2021 | 402.40 Mn |